Williams Lea has been providing Corporate Information Solutions to GSK’s (a world-leading research-based pharmaceutical company) legacy companies for six years, particularly in the production of submission documents and case report forms (CRFs), both business-critical elements of the drug development process.

As GSK’s strategic partner for UK reprographics, Williams Lea rose to this challenge. A 12 month programme of process re-engineering was initiated to significantly improve management of clinical trial documents across the organisation, speeding up the process without compromising document quality and personalisation.

Results

• Significant cost savings, freeing funds for reinvestment in pursuit of new medicines
• Enhanced processes associated with the drug development cycle
• Throughput increased by almost 110% on existing equipment through efficient utilisation of client-owned equipment
• Equipment rationalisation has led to estimated equipment savings of more than £100,000 per year
• Improved production processes through the implementation of best-in-breed, digital technology (our manufacturer independence enabled us to implement equipment which best suited GSK’s requirements)
• Introduction of single technology platform for CRF production
  
    Click here to view the full case study.